A controlled study of intravenous doxorubicin versus oral tegafur in patients with hepatocellular carcinoma.

Sorry, there's nothing here.

Cite this paper

@article{Okazaki1985ACS, title={A controlled study of intravenous doxorubicin versus oral tegafur in patients with hepatocellular carcinoma.}, author={Noriko Okazaki and Masataka Yoshino and T Yoshida and Atsushi Hijikata}, journal={Nihon Gan Chiryo Gakkai shi}, year={1985}, volume={20 3}, pages={556-61} }